Fact.MR Foresees a Moderate Growth for Global Meatainers Market during 2017 – 2026
/
Date09 Mar 2018
Rockville, MD , March 09, 2018 (GLOBE NEWSWIRE) — Pivotal role of packaging containers in the storing and transportation of fresh or processed meat keeps... Read More →
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
/
Date09 Mar 2018
DUBLIN, Ireland, March 09, 2018 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq AVDL), “Avadel” or “the Company,” today announced that management will present at two... Read More →
European Commercial REIT Announces Q1 2018 Quarterly Cash Distribution
/
Date09 Mar 2018
TORONTO, March 08, 2018 (GLOBE NEWSWIRE) — European Commercial Real Estate Investment Trust (“ECREIT”) (TSX-V:ERE.UN) announced today its regular quarterly cash distribution, in respect of... Read More →
UTStarcom Reports Unaudited Financial Results for the Fourth Quarter and Full Year 2017
/
Date09 Mar 2018
HONG KONG, March 09, 2018 (GLOBE NEWSWIRE) — UTStarcom (“UTStarcom” or “the Company”) (NASDAQ:UTSI), a global telecommunications infrastructure provider, today reported its unaudited financial results... Read More →
Alphatec Spine Disrupts Market with Acquisition of SafeOp Surgical, ~$50M Equity Financing, and Strategic Leadership Appointments
/
Date09 Mar 2018
Acquisition provides Alphatec most advanced automated neuromonitoring technology Private placement funded by senior leadership, new and existing investors Luiz Pimenta, MD, PhD, to assume role... Read More →
Metrospaces Announces That it Will Not Honor Notice of Conversion for 3(a)10 Due to Potential Fraud Against the Company
/
Date09 Mar 2018
NEW YORK, NY, March 09, 2018 (GLOBE NEWSWIRE) — Metrospaces, Inc. (OTC: MSPC) announces that it won’t honor any notice of conversion for common shares... Read More →
Investeringsforeningen MS Invest
/
Date09 Mar 2018
Bestyrelsen for Investeringsforeningen MS Invest har på bestyrelsesmøde d.d. godkendt årsrapporten for 2017. Årsrapporten er vedhæftet.
Callitas Health, Inc Receives Notice of Allowance from USPTO for Patent Application for Treatment for Male Infertility and Sub-Fertility
/
Date09 Mar 2018
CINCINNATI, OH , March 08, 2018 (GLOBE NEWSWIRE) — Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) a clinical-stage company developing... Read More →
BioXcel Therapeutics Announces Pricing of Initial Public Offering
/
Date09 Mar 2018
BRANFORD, Conn., March 08, 2018 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI”), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the... Read More →